Doug Niemann - Athene Holding Executive Vice President Chief Risk Officer
Insider
Doug Niemann is Executive Vice President Chief Risk Officer of Athene Holding since 2020.
| Age | 50 |
| Tenure | 4 years |
| Phone | 441-279-8400 |
| Web | https://www.athene.com |
Athene Holding Management Efficiency
The company has Return on Asset of 1.36 % which means that on every $100 spent on assets, it made $1.36 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 20.13 %, implying that it generated $20.13 on every 100 dollars invested. Athene Holding's management efficiency ratios could be used to measure how well Athene Holding manages its routine affairs as well as how well it operates its assets and liabilities.Athene Holding has 2.47 B in debt with debt to equity (D/E) ratio of 0.11, which may show that the company is not taking advantage of profits from borrowing. Athene Holding has a current ratio of 4.01, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Athene to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Lappe | Inhibrx | 57 | |
| Sierk Poetting | BioNTech SE | 51 | |
| Marisol Bravo | Compania Cervecerias Unidas | 64 | |
| Ryan Richardson | BioNTech SE | 45 | |
| Sebastian Landi | Compania Cervecerias Unidas | 45 | |
| Marcus Dijk | Mink Therapeutics | 62 | |
| Soon Goh | CapitaLand Investment Limited | 48 | |
| Claudio Heras | Compania Cervecerias Unidas | N/A | |
| Martn Rodriguez | Compania Cervecerias Unidas | 63 | |
| BS CPA | Inhibrx | 42 | |
| Kimberly Ha | Mink Therapeutics | N/A | |
| Cho CFA | CapitaLand Investment Limited | 53 | |
| Patricio Nasrallah | Compania Cervecerias Unidas | 61 | |
| Simon Treacy | CapitaLand Investment Limited | 54 | |
| Barbara Wood | Sellas Life Sciences | 61 | |
| Marc Gross | Compania Cervecerias Unidas | 62 | |
| Blake Schuhmacher | Westrock Coffee | 46 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Jrg Breitkopf | Sellas Life Sciences | N/A | |
| ScD MD | Sellas Life Sciences | 48 | |
| Ozlem MD | BioNTech SE | 57 | |
Management Performance
| Return On Equity | 20.13 | |||
| Return On Asset | 1.36 |
Athene Holding Leadership Team
Elected by the shareholders, the Athene Holding's board of directors comprises two types of representatives: Athene Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Athene. The board's role is to monitor Athene Holding's management team and ensure that shareholders' interests are well served. Athene Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Athene Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gernot Lohr, Director | ||
| Randall Epright, Executive Vice President and Chief Information Officer, Athene Holding Ltd | ||
| Michael Downing, Executive Vice President and Chief Actuary | ||
| Manfred Puffer, Director | ||
| Marc Rowan, Director | ||
| Marc Beilinson, Lead Independent Director | ||
| William Wheeler, President | ||
| Mitra Hormozi, Independent Director | ||
| Kristi Burma, Executive Vice President - Human Resources | ||
| Lynn Swann, Independent Director | ||
| H McCall, Independent Director | ||
| Fehmi Zeko, Independent Director | ||
| Lawrence Ruisi, Independent Director | ||
| Martin Klein, Chief Financial Officer, Executive Vice President | ||
| James Belardi, Chairman of the Board, Chief Executive Officer, Chief Investment Officer | ||
| Brian Leach, Independent Director | ||
| Matthew Michelini, Director | ||
| Hope Taitz, Independent Director | ||
| Scott Kleinman, Director | ||
| Sarah VanBeck, Senior Vice President Principal Accounting Officer, Controller | ||
| Arthur Wrubel, Independent Director | ||
| Doug Niemann, Executive Vice President Chief Risk Officer | ||
| Robert Borden, Independent Director | ||
| Grant Kvalheim, Executive Vice President - Athene, Chief Executive Officer and President - Athene USA | ||
| John Golden, Executive Vice President, General Counsel |
Athene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Athene Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 20.13 | |||
| Return On Asset | 1.36 | |||
| Profit Margin | 13.69 % | |||
| Operating Margin | 16.05 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 192.14 M | |||
| Shares Owned By Insiders | 2.98 % | |||
| Shares Owned By Institutions | 87.92 % | |||
| Number Of Shares Shorted | 5.02 M | |||
| Price To Earning | 4.42 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Athene Stock
If you are still planning to invest in Athene Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athene Holding's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |